S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
OTCMKTS:OSIR

Osiris Therapeutics (OSIR) Stock Forecast, Price & News

$18.99
0.00 (0.00%)
(As of 04/17/2019)
Compare
Today's Range
$18.99
▼
$18.99
50-Day Range
$18.99
▼
$18.99
52-Week Range
$7.01
▼
$19.30
Volume
N/A
Average Volume
205,753 shs
Market Capitalization
$655.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC Filings

OSIR stock logo

About Osiris Therapeutics (OTCMKTS:OSIR) Stock

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints. The company also develops and markets Menvivo for the repair of meniscus; and TruSkin for treating chronic wounds. It markets and distributes its products directly to physicians, hospitals, and other healthcare providers, as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Receive OSIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osiris Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OSIR Stock News Headlines

May 30, 2023 | finance.yahoo.com
Tissue Engineering Global Market Report 2023
May 23, 2023 | finance.yahoo.com
Global Cell Therapy Market Report 2023: Growing Approvals for Cell-based Therapies Fuels the Sector
June 3, 2023 | Legacy Research (Affiliate) (Ad)
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
May 23, 2023 | americanbankingnews.com
Reviewing Osiris Therapeutics (OTCMKTS:OSIR) and REGENXBIO (NASDAQ:RGNX)
May 22, 2023 | markets.businessinsider.com
Vesselon Discovery Protects and Expands Drug Franchises
May 17, 2023 | marketwatch.com
Biological Derived Devices Market Reports, Scope, Methodology, Timelines And Challenges Forecast Till 2030
May 17, 2023 | marketwatch.com
Allogeneic Stem Cells Market Research Report Analysis the Regions, and International Markets Forecast (2023-2030)
May 17, 2023 | marketwatch.com
Global Stem Cells Market [2023-2030] | Growth Rate (CAGR) at a 10.9% | Expected to Reach Worth 5727.2
June 3, 2023 | Legacy Research (Affiliate) (Ad)
The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
May 17, 2023 | marketwatch.com
Stem Cells Market Size Will Have Significant Potential in Future Reaching Over USD 37,800 Million by 2032
May 16, 2023 | marketwatch.com
Stem Cells Market Growth Opportunities Till 2030
May 12, 2023 | marketwatch.com
Tissue Engineering Market Size in 2023-2030: Competitive landscape and Leading Country
May 11, 2023 | marketwatch.com
Cartilage Repair& Cartilage Regeneration Market Forecast 2023-2030
May 9, 2023 | marketwatch.com
Stem Cell Therapy Market Outlook and Forecast till 2030
May 9, 2023 | marketwatch.com
2030, Stem Cell Therapy Market: Growth & Statistics
May 8, 2023 | marketwatch.com
Stem Cell Therapy Market Research | 2023-2030
May 8, 2023 | marketwatch.com
Global Allograft Market by [2023-2029] with Revenue Outsourcing
May 5, 2023 | marketwatch.com
Graft Versus Host Disease (GVHD) Treatment Market by Product Type and Consumers-2030
May 4, 2023 | marketwatch.com
Global Stem Cell Therapy Market [2023-2030] | Growing at a CAGR of 19.7% | An Overview of Market Trends and Projections
May 3, 2023 | marketwatch.com
Allogeneic Stem Cells Market Growth and Size 2031
May 2, 2023 | marketwatch.com
Exploring the Growth Potential of the Regenerative Medicine Products Market till 2031
April 30, 2023 | marketwatch.com
Active Wound Care Market Size, Share, Growth Rate, Geographic Segmentation, Key Players Analysis To 2030
April 29, 2023 | marketwatch.com
Diabetic Foot Ulcer Therapeutics Market Growth by 2030
April 29, 2023 | marketwatch.com
Global Stem Cell Therapy Market by [2023-2029] with Revenue Outsourcing
April 28, 2023 | marketwatch.com
Global Active Wound Care Market Size, Share and Trend Analysis 2028
April 28, 2023 | marketwatch.com
Allogeneic Stem Cells Market: Segments Analysis and Future Growth Trends By 2030
April 27, 2023 | marketwatch.com
Pancreatic Beta-Cell Protection Market Top Key Players by 2031
See More Headlines

OSIR Price History

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
OTCMKTS:OSIR
Previous Symbol
NASDAQ:OSIR
CUSIP
68827R10
CIK
1360886
Web
www.osiristx.com
Phone
443-545-1800
Fax
N/A
Employees
N/A
Year Founded
1992

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,528,000
Free Float
N/A
Market Cap
$655.69 million
Optionable
Optionable
Beta
N/A

Social Links


Key Executives

  • Mr. Jason Keefer (Age 46)
    Interim Pres & CEO
  • Dr. Alla N. Danilkovitch (Age 54)
    Chief Scientific Officer
  • Mr. Joel David Rogers (Age 56)
    Interim Chief Financial Officer
  • Mr. Edward Yip
    Chief Legal Officer & Corp. Sec.
  • Mr. Laine Dyess
    VP of Sales

Key Competitors

View All Competitors













OSIR Stock - Frequently Asked Questions

How have OSIR shares performed in 2023?

Osiris Therapeutics' stock was trading at $18.99 at the beginning of 2023. Since then, OSIR shares have increased by 0.0% and is now trading at $18.99.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Osiris Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Osiris Therapeutics investors own include Sierra Wireless (SWIR), Achillion Pharmaceuticals (ACHN), Fate Therapeutics (FATE), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Aerie Pharmaceuticals (AERI), Cytokinetics (CYTK) and Depomed (DEPO).

What is Osiris Therapeutics' stock symbol?

Osiris Therapeutics trades on the OTCMKTS under the ticker symbol "OSIR."

How do I buy shares of Osiris Therapeutics?

Shares of OSIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Osiris Therapeutics' stock price today?

One share of OSIR stock can currently be purchased for approximately $18.99.

How much money does Osiris Therapeutics make?

Osiris Therapeutics (OTCMKTS:OSIR) has a market capitalization of $655.69 million.

How can I contact Osiris Therapeutics?

Osiris Therapeutics' mailing address is 7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD, 21046. The official website for the company is www.osiristx.com. The biotechnology company can be reached via phone at 443-545-1800 or via email at osirispr@osiris.com.

This page (OTCMKTS:OSIR) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -